Lichen sclerosus (LS) is a chronic inflammatory mucocutaneous disease with uncertain etiology. It occurs as white plaque-like lesions mostly in the anogenital skin. Oral mucosal involvement is extremely rare. This study aims to summarize the features of published oral lichen sclerosus (OLS) and two new cases. A systematic search of the English literature from 1955 to 2016 was performed in MEDLINE, Scopus, and Web of Science, and crossreferences were searched manually. Search phrases included "lichen sclerosus," "mouth," "oral," "lip," "palate," "floor of mouth," "tongue," "gingiva," "buccal mucosa," and "mouth diseases." Cases with clinical and histopathological confirmation of diagnosis of OLS were included. A total of 41 (39 published and 2 new) histologically confirmed OLS cases were available. The median age of OLS patients was 31 years, and 66% of the patients were female. Most of the OLS lesions were asymptomatic. They were located in the labial mucosa (n = 20), lip (n = 15), buccal mucosa (n = 14), gingiva (n = 12), tongue (n = 12), and palate (n = 7). OLS is rare and typically presents as asymptomatic, white, plaque-like lesions. Malignant transformation of preexisting OLS has not been reported.
Introduction
Lichen sclerosus (LS) is a relatively rare chronic inflammatory mucocutaneous disease of uncertain etiology. The prevalence of LS is estimated to be 0.1-0.3%. 1 The disease is more common in women and may be found in both children and adults with a typical onset before puberty in children, after menopause in women, and in the fourth decade in men. 2 LS was first described in 1887 by Hallopeau in his article "Du lichen plan et particuli erement de sa forme atrophique: lichen plan scl ereux." 3 LS involving the oral mucosa was first described by Miller in 1957. 4 LS has been previously called lichen sclerosus et atrophicus and balanitis xerotica obliterans, but the name was changed to lichen sclerosus in 1976
by the International Society for the Study of Vulvar Disease, because atrophy is not always present in the lesions. 5 LS presents clinically as ivory or porcelain-white, polygonal, flat-topped papules, plaques, or atrophic patches. 6 LS occurs mainly in the anogenital area but may arise anywhere on the skin with upper back, chest, and breasts affected most frequently. 6 About 60% of women with genital LS have symptoms. 6 The symptoms of genital LS are itching, fissuring, erosion, dysuria, urethral and vaginal discharge, dyspareunia, and burning pain in females and hemorrhage, shallow erosions, phimosis, paraphimosis, and urethral meatus stenosis in men.
Cutaneous LS is usually asymptomatic but can feature pain and pruritus. Genital LS is associated with an increased risk of malignant transformation. 6 Differently, malignant change in extragenital LS lesions is extremely rare. 7 The etiological factors of LS are still uncertain, but infections (e.g. Borrelia burgdorferi and Epstein-Barr virus infections), autoimmune reactions, irritation (urine), hormones, and genetic factors have been suggested to play a role in the pathogenesis. 2 A growing consensus is that LS has an autoimmune etiology in genetically susceptible individuals. 2, 8 The most characteristic histopathological feature of LS is hyalinization of the lamina propria. 8 Early LS lesions show 9 OLS is rarely symptomatic but can cause pain, soreness, pruritus, and tightness when opening the mouth. [10] [11] [12] [13] [14] [15] [16] [17] Gingival lesions may cause gingival recession, loss of periodontal attachment, and even tooth mobility. 13, 14, 16 Malignant transformation of OLS has not been reported.
The aim of this study was to summarize the demographic and clinicopathologic data of LS involving the oral cavity and lips for the first time in a systematic review. In addition, we report two new cases of OLS.
Materials and methods
The review was done according to the PRISMA statement guidelines. Three databases were searched for English case reports and case series of OLS (Fig. 1) . Search phrases included "lichen sclerosus," "mouth," "oral," "lip," "palate," "floor of mouth," "tongue," "gingiva," "buccal mucosa," and "mouth Case 2 A 51-year-old generally healthy, nonsmoking woman with two oral lesions was seen at Kainuu Central Hospital in Kajaani.
One of the lesions was bullous and located on the palatal mucosa, whereas the other lesion, resembling leukoplakia, was found on maxillary alveolar mucosa. The clinical features were suspicious for mucous membrane pemphigoid.
The palatal lesion was excised. Histological examination showed subepithelial blister formation and homogenization, hyalinization of collagen fibers, hydropic degeneration of the basal cells, band-like lymphocytic inflammatory infiltrate in the connective tissue, telangiectasia, and lack of elastic fibers (Fig. 2f, g ). The amount of melanocytes was within normal range. The patient was given the diagnosis of LS. Later, LS lesions were also found in the vulva and perineum. At a followup examination after 18 months, no new lesions were found.
Results
Literature review yielded a total of 39 histologically proven cases of OLS (Fig. 1) . Most papers reported only one case (n = 25), one reported six cases, 17 and four reported two cases. [18] [19] [20] [21] The present report adds two new cases of histologically confirmed OLS, raising the total number so far to 41. Summary of the demographic and clinical characteristics of the OLS cases is presented in Table 1 . More detailed data about the patient characteristics are shown in Table S1 . OLS was reported from four continents (Asia, Europe, North America, and South America). Mean age among the patients was 34 years (range 7-70). Sixty-six percent of the patients were female. Five of the patients, including present case 1, were smokers, 21 were nonsmokers, and for the rest, the reports did not specify whether or not the patients smoked cigarettes.
Twenty-one (70%) patients were generally healthy. Nine (30%) patients were reported to have medical problems: asthma (n = 3), hyperthyroidism (n = 2), partial albinism, carcinoma of the cervix, seroresistant syphilis, and dermatitis venenata (n = 1), hypertension (n = 1), alcoholism (n = 1), slight anemia (n = 1), and multiple sclerosis (n = 1). General medical status was not reported for 11 patients. Only three cases were reported to have allergies. Of note, the vast majority of case reports did not specifically state whether or not the patients had allergies.
Most oral lesions presented as white, homogenous plaques on the oral mucosa or lip. Occasionally, associated telangiectasias 20, 22, 23 or erosions 11 were reported. Labial mucosa, buccal mucosa, and lip were the most common locations of the OLS lesions, followed by gingiva and tongue. Notably, floor of the mouth mucosa was not affected by OLS in any of the patients.
The majority of the patients were asymptomatic; only less than one-third had symptoms including pain, pruritus, and tightness when opening the mouth. Gingival involvement by OLS caused soreness associated with tooth brushing in some patients. Gingival recessions, periodontal attachment loss, and tooth mobility were also reported. [12] [13] [14] 16 In one case, this led to loss of teeth in the affected area. 13 Thirty-one percent of the patients had skin lesions, and 18% had genital lesions. The oral LS lesions occurred concurrently with the extraoral lesions in eight cases, after the onset of extraoral lesions in five cases, and before the onset of extraoral lesions in two cases.
Two-thirds of the patients received some form of treatment. The most common medications to manage the OLS symptoms were topical corticosteroids (n = 10), intralesional corticosteroids (n = 6), and topical calcineurin inhibitors tacrolimus (n = 4) and pimecrolimus (n = 1). Five patients were treated surgically ( Table 1 ). The other, less commonly used treatments included systemic corticosteroids (n = 2), systemic colchicine (n = 2), methotrexate, topical testosterone, systemic vitamin D2 with systemic and topical pantothenyl alcohol, Solcoseryl, and griseofulvin. Topical corticosteroids resulted in partial response in 67% (6/9) of the patients, and in no response in 33% (3/9) of the patients (Table S1 ). In one patient, the response to topical 
Discussion
OLS typically presents with whitish, ivory-or porcelain-white macules or plaques with well-demarcated borders. 21, 24 These clinical features may mimic other chronic, white, plaque-type lesions, such as plaque-like lichen planus, leukoplakia, chronic hyperplastic candidiasis, oral submucous fibrosis, and localized scleroderma (morphea). 6, 12 In addition, some OLS cases may show characteristics of autoimmune bullous disease. 2 Early LS lesions may histologically have overlapping features with lichen planus or psoriasis, 2 but more mature lesions often show lack of elastic fibers without band of lymphocytes at epithelium-connective tissue junction, unlike lichen planus. 12 For histological distinction from morphea, Verhoeff's histochemical staining may be used to show the loss of elastic fibers in LS biopsies. The main clinical and histopathological differential diagnoses of OLS are presented in Table 2 .
The age range in OLS is wide, with a mean age of 34.
Hence, OLS patients are typically younger than patients with lichen planus, leukoplakia, or chronic hyperplastic candidiasis.
OLS patients are often older than oral submucosis fibrosis There is some evidence of genetic background for the development of LS. Sherman et al. 35 found that 12% of female LS patients had a positive family history of LS. In addition, several major histocompatibility complex genes occur more often in LS patients than in controls. 31, 32, [35] [36] [37] [38] [39] [40] IF examination of biopsy was performed in four cases, 12, 14, 41 and It is therefore possible that the present cases were bullous forms of LS in their early presentation.
As a result of the small number of patients, randomized controlled trials are difficult to conduct in OLS. Therefore evidencebased treatment recommendations for OLS are not available. The risk of genital LS lesions developing malignant change has been estimated to be 0.3-4.9% for women and 9.3% for men. 2 Questioning the relatively high malignant transformation rate of LS, a study by van der Nieuwenhof et al. 49 shows that a significant proportion of cases initially diagnosed as vulvar LS, and that progressed to squamous cell carcinoma, were on revision in fact diagnosed as vulvar intraepithelial neoplasia. Thus, LS may not be a precancerous condition as such but a chronic scarring process in an environment where carcinogenesis could be enhanced. 8 No malignant transformation was reported amongst the 41 cases of OLS in this review. However, the follow-up of the patients was generally short.
Among the strengths of this study is the systematic search of three comprehensive databases. There have been other reviews of OLS, 17, 21, 24, 50, 51 but these were not systematic reviews. The weakness of this review is that some relevant articles may have been excluded owing to limiting the language to English, and that there might exist articles not included in the three aforementioned databases. We were able to retrieve information from all the case reports and case series that fulfilled the inclusion criteria; therefore we consider this review to be of low risk of bias regarding data collection. In addition, all the data were analyzed by two researchers.
Conclusions
OLS is very rare but should be included in the differential diagnosis of white plaque-like lesions of the oral mucosa. In case of symptomatic lesions, topical or intralesional corticosteroids are the first-line therapy. Surgical excision, if feasible, may achieve complete response. Topical calcineurin inhibitors may be used in cases not responding to topical steroids. Malignant potential of OLS remains currently unsolved.
